Baltimore, MD - June 6, 2011 - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today it has hired Margaret A. Connolly, Ph.D. as Senior Statistician.

As consulting statistician Dr. Connolly recently assisted in completing a late Phase 2 vaccine clinical study report under Department of Defense contract and developed the statistical analysis plan with programming specifications for time to event endpoints derived from interactive voice response diary data for another client.  She was a key member that developed a successful sNDA based on planned retrospective analysis of data collected from published non-GCP studies and from clinical sites with documented off-label use. 

Dr. Connolly served as the Director of Biostatistics with GloboMax LLC through its transition to ICON Development Solutions, the regulatory consulting and Phase 1 trials division of an international contract research organization conforming to GxP and ISO 9000 quality standards.  

Dr. Connolly has a Ph.D. in Biostatistics from Johns Hopkins University, an MS from Michigan State University, and BS from Cornell University.  She has also written for publications and presented at several clinical trial venues.

Dr. Bruce Thompson, CEO stated, “I am very excited to have a fellow alumnus from the Johns Hopkins University Department of Biostatistics.  Margaret has an outstanding history of collaboration with pharmaceutical companies and is a welcome addition to the C-TASC staff.”

  "I always enjoy exploring new data and it will be a real pleasure for me to consult on scientific questions and solve operational challenges of diverse databases managed by C-TASC clinical coordination services." stated Dr Connolly, "The added benefit will be to work with colleagues who demonstrate high standards for innovation and rigor combined with reliable data management strategies."